Mylan says Allergan misusing tribal sovereignty in patent dispute Ruby Khatun Khatun15 Sept 2017 9:56 AM ISTNEW YORK: Generic drugmaker Mylan NV alleged in a court filing that rival Allergan Plc is trying to take advantage of Native American sovereignty to...
Novartis says biosimilar rituximab accepted for review by FDA Ruby Khatun Khatun15 Sept 2017 9:26 AM ISTZURICH: Novartis AG said on Tuesday its biosimilar rituximab to treat blood cancers and immunological diseases such as rheumatoid arthritis were...
Blockbuster cancer drug Keytruda launched in India Ruby Khatun Khatun14 Sept 2017 11:29 AM ISTNew Delhi: US-based drug major MSD said it has launched cancer drug Keytruda in India for treatment of advanced melanoma, a form of skin cancer.The...
Pharma Bro ordered jailed for online bounty on Hillary Clintons hair Ruby Khatun Khatun14 Sept 2017 10:53 AM ISTA U.S. judge on Wednesday ordered Martin Shkreli to be jailed while he awaits sentencing for securities fraud, citing a Facebook post in which the...
Medtronic announces voluntary recall of Diabetes Infusion Sets MiniMed worldwide Ruby Khatun Khatun14 Sept 2017 10:37 AM ISTDUBLIN: Medtronic plc announced that it has started to inform patients worldwide of a voluntary recall of specific lots of infusion sets used with all...
Lupins US arm recalls 12,888 bottles of ulcer drug in US Ruby Khatun Khatun14 Sept 2017 10:02 AM ISTNew Delhi: Drug firm Lupin's US arm, Lupin Pharmaceuticals Inc, is recalling 12,888 bottles of Famotidine for oral suspension used in the treatment of...
Johnson and Johnson arm Janssen to discontinue Hepatitis C development program Ruby Khatun Khatun14 Sept 2017 10:02 AM ISTCORK, Ireland: Janssen Sciences Ireland UC (Janssen), announced a strategic decision to discontinue further development of the investigational...
US tribal patent deal could have big impact on generic drug market Ruby Khatun Khatun14 Sept 2017 9:45 AM ISTA groundbreaking deal between Allergan Plc and a Native American tribe to shield the company's patents in administrative proceedings could also be...
Bristols drug cocktail cuts kidney cancer death risk 37 percent Ruby Khatun Khatun14 Sept 2017 9:25 AM ISTMADRID: A combination of two Bristol-Myers Squibb immunotherapy drugs cut the risk of death by 37 percent in a key group of kidney cancer patients,...
Lupin to add GLP 1 analog to its diabetes portfolio in India Ruby Khatun Khatun13 Sept 2017 3:07 PM ISTMumbai: Lupin plans to introduce a new class of diabetes drugs in India through in-licensing agreements in order to enhance its diabetes drugs...
Glenmark gets USFDA approval for Rythmol SR generic Ruby Khatun Khatun13 Sept 2017 2:08 PM ISTNew Delhi: Glenmark Pharmaceuticals has received final approval from the US health regulator for the generic version of Rythmol SR capsules, an...
Panacea Biotec extends distribution pact with Canadian firm for US Ruby Khatun Khatun13 Sept 2017 1:43 PM ISTNew Delhi: Drug firm Panacea Biotec on Monday said it has expanded its existing collaboration with Canada's Apotex Inc for sales and distribution of...
